Craig Gracey - 13 Jul 2026 Form 4 Insider Report for Omada Health, Inc. (OMDA)

Reporting relationship: Chief Accounting Officer
Issuer ticker: OMDA
Reported as of: 13 Jul 2026
Net transaction value: -$24,984
SEC form: 4
Accepted by SEC: 15 Jul 2026, 16:33:32 UTC
Prior SEC filing: 02 Jul 2026
Source filing: View source filing
Reporting owner signature: /s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey

Key filing fact

Craig Gracey filed Form 4 for Omada Health, Inc. (OMDA) on 15 Jul 2026.

Key facts

This page summarizes Craig Gracey's Form 4 filing for Omada Health, Inc. (OMDA).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 15 Jul 2026, 16:33.

Change

Previous filing in this sequence was filed on 02 Jul 2026.
Current net transaction value: -$24,984.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002021724 Primary reporting owner

Gracey Craig

Relationship: Chief Accounting Officer
Address: C/O OMADA HEALTH, INC., 611 GATEWAY BLVD, SUITE 120, SOUTH SAN FRANCISCO
Signature: /s/ Nathan Salha, as Attorney-in-Fact for Craig Gracey
Signature date: 15 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OMDA transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,041
Change %: +6.7%
Price: $6.57^*
Shares after: 16,482
Date: 13 Jul 2026
Ownership: Direct

OMDA transaction

Common Stock

Sale

Transaction value: $24,984
Shares: -1,041
Change %: -6.3%
Price: $24.00
Shares after: 15,441
Date: 13 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OMDA transaction Derivative

Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares: -1,041
Change %: -3%
Price: $0.000000^*
Shares after: 33,334
Date: 13 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,041
Exercise price: $6.57
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 13, 2026.

Footnote F2

25% of the shares subject to the option vest on the first anniversary measured from September 9, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.